Physician profile
Carla Gomes
NPI 1720446362
$1,247.61
in general payments reported to CMS, 2019-2025
16 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.10 · 2023: $479 · 2024: $404 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.92 | 2024-2025 | Lifevest |
| Acadia Pharmaceuticals INC | $219.80 | 2023 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2025 | Rexulti |
| Abbott Laboratories | $112.50 | 2024 | Cardiomems |
| Novo Nordisk INC | $81.17 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Lundbeck LLC | $59.12 | 2023 | Rexulti |
| Shield Therapeutics INC | $58.08 | 2023-2024 | Accrufer |
| Novartis Pharmaceuticals Corporation | $52.68 | 2024-2025 | |
| Abbvie INC. | $47.10 | 2022 | |
| Exact Sciences Corporation | $41.98 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $37.66 | 2024 | Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.56 | 2023 | Xifaxan |
| Amgen INC. | $23.08 | 2023 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $22.90 | 2023 | Vaxneuvance, Gardasil 9 |
| Pfizer INC. | $22.81 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Gomes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.